These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1799604)

  • 1. [Assessment of rate constants for isolating a metabolite by a model-independent method].
    Piotrovskiĭ VK
    Biofizika; 1991; 36(5):899-903. PubMed ID: 1799604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone].
    Ding JJ; Jiao Z; Yu YQ; Shi XJ
    Yao Xue Xue Bao; 2007 Jun; 42(6):631-8. PubMed ID: 17702401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.
    Piotrovskii VK
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):311-8. PubMed ID: 1875284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of theophylline metabolism in man.
    Miller CA; Slusher LB; Vesell ES
    J Clin Invest; 1985 May; 75(5):1415-25. PubMed ID: 4039734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.
    Weiss M
    Drug Metab Dispos; 1998 Jun; 26(6):562-5. PubMed ID: 9616192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A simple method for predicting equality of absorption and elimination rate constants].
    Li JW; Zhang CL
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):392-4. PubMed ID: 2130592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of radiotracers in human plasma during positron emission tomography.
    Cumming P; Yokoi F; Chen A; Deep P; Dagher A; Reutens D; Kapczinski F; Wong DF; Gjedde A
    Synapse; 1999 Nov; 34(2):124-34. PubMed ID: 10502311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy for removing the bias in the graphical analysis method.
    Logan J; Fowler JS; Volkow ND; Ding YS; Wang GJ; Alexoff DL
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):307-20. PubMed ID: 11295885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model based assessment of redistribution dependent elimination and bioavailability of rifabutin.
    Li RC; Narang PK; Poggesi I; Strolin-Benedetti M
    Biopharm Drug Dispos; 1996 Apr; 17(3):223-36. PubMed ID: 8983397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of models for analysis of radioligand binding data.
    Abramson SN; McGonigle P; Molinoff PB
    Mol Pharmacol; 1987 Jan; 31(1):103-11. PubMed ID: 3027522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.
    Wajima T; Yano Y; Oguma T
    J Pharm Pharmacol; 2002 Jul; 54(7):929-34. PubMed ID: 12162711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
    Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
    Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multiple depletion curves method provides accurate estimates of intrinsic clearance (CLint), maximum velocity of the metabolic reaction (Vmax), and Michaelis constant (Km): accuracy and robustness evaluated through experimental data and Monte Carlo simulations.
    Sjögren E; Lennernäs H; Andersson TB; Gråsjö J; Bredberg U
    Drug Metab Dispos; 2009 Jan; 37(1):47-58. PubMed ID: 18824525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.
    Pang KS
    Drug Metab Dispos; 1995 Feb; 23(2):166-77. PubMed ID: 7736907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect.
    Fujimiya T; Fukui Y; Komura S
    Nihon Hoigaku Zasshi; 1995 Apr; 49(2):92-103. PubMed ID: 7783393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary.
    Pang KS; Gillette JR
    Drug Metab Dispos; 1980; 8(1):39-43. PubMed ID: 6102028
    [No Abstract]   [Full Text] [Related]  

  • 20. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.